Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)
The Companies intend to first initiate a Phase 2a clinical trial evaluating Xyngari™ with Daxxify® to treat primary axillary ...
Dermata, Revance test new hyperhidrosis treatment
SAN DIEGO, CA - Dermata Therapeutics , Inc. (NASDAQ:DRMA) and Revance Therapeutics, Inc. (Nasdaq: NASDAQ:RVNC), two ...
Baylor College of Medicine4y
Botulinum Toxin
Botulinum toxin (BTX) has been used at Baylor’s Parkinson’s Disease ... Though there are several formulations of BTX approved by the US FDA. Type A BTX formulations include onabotulinumtoxinA (Botox), ...
Healio5d
Clear patient communication, understanding of anatomy key when using botulinum toxin
Proper patient communication is the key to achieving good outcomes when administering botulinum toxin, according to a speaker ...
Daily2d
Botulinum Toxin Shows Promise for Treating Raynaud’s Phenomenon in Scleroderma: Study Reveals
UK: A recent systematic review published in Clinical Rheumatology has investigated the potential of botulinum toxin (BTX) as ...
emjreviews.com16d
Exploring Botulinum Toxin for Raynaud’s Treatment
Botulinum toxin (BTX), widely known for its cosmetic and neurological applications, is emerging as a potential treatment for Raynaud’s phenomenon (RP), particularly when secondary to scleroderma.
Business Insider4y
Babies can't eat honey because the bacteria can cause infant botulism
Honey contains C. botulinum bacteria, which can produce a toxin in a baby's large intestine, leading to a rare but serious illness known as "infant botulism." Following is a transcript of the video.
psychiatryadvisor.com9d
Vibration Anesthesia Reduces Pain During Botulinum Toxin Injection
Vibration anesthesia during botulinum toxin injections for masseter reduction is a safe and effective option for pain management.